Development of an Interferon-γ ELISPOT Assay to Assess Varicella-Zoster Virus-Specific Cell-Mediated Immunity in Children
Infection & Chemotherapy · 2026 · 58
DOI: 10.3947/ic.2026.0039 ↗Kurz gefasst
Fachartikel in der Zeitschrift Infection & Chemotherapy, 2026. Verfasst von Mi Seon Han und 1 weiteren Autor:innen. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Korean Society of Pediatric Infectious Diseases.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- Korean Society of Pediatric Infectious Diseases
Zitieren
APA
Han, M. S., & Choi, E. H. (2026). Development of an Interferon-γ ELISPOT Assay to Assess Varicella-Zoster Virus-Specific Cell-Mediated Immunity in Children. Infection & Chemotherapy, 58. https://doi.org/10.3947/ic.2026.0039
Vancouver
Han MS, Choi EH. Development of an Interferon-γ ELISPOT Assay to Assess Varicella-Zoster Virus-Specific Cell-Mediated Immunity in Children. Infection & Chemotherapy. 2026;58. doi:10.3947/ic.2026.0039
BibTeX
@article{Han2026,
author = {Han, Mi Seon and Choi, Eun Hwa},
title = {Development of an Interferon-γ ELISPOT Assay to Assess Varicella-Zoster Virus-Specific Cell-Mediated Immunity in Children},
journal = {Infection & Chemotherapy},
year = {2026},
volume = {58},
doi = {10.3947/ic.2026.0039}
}
EUVIMED